KEMPHARM, INC Human Resources Contracts & Agreements
34 Contracts & Agreements
- Bonus & Incentive Agreements (4 contracts)
- Compensation Agreements (9)
- Consulting Agreements (1)
- Employment Agreements (17)
- Separation Agreements (1)
- Transition Agreements (2)
- 2023 Employment Inducement Award Plan and forms of award agreements thereunder (Filed With SEC on April 1, 2024)
- Employment Agreement, effective as of October 10, 2023,between Zevra Therapeutics, Inc. and Neil F. McFarlane (Filed With SEC on October 10, 2023)
- Ninth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 14, 2023)
- Agreement Regarding Employment Terms, dated as of May 13, 2023, between Zevra Therapeutics, Inc. and Christal M.M. Mickle (Filed With SEC on May 15, 2023)
- Transition Agreement, dated as of May 6, 2023, between Zevra Therapeutics, Inc. and Richard W. Pascoe (Filed With SEC on May 8, 2023)
- 2023 Employment Inducement Award Plan and forms of award agreements thereunder (Filed With SEC on March 7, 2023)
- EighthAmended and Restated Non-Employee Director Compensation Policyeffective February 15, 2023 (Filed With SEC on March 7, 2023)
- Consulting Agreement, dated as of January 6, 2023, between KemPharm, Inc. and Travis C. Mickle, Ph.D (Filed With SEC on January 9, 2023)
- Transition Agreement, dated as of January 4, 2023, as amended, between KemPharm, Inc. and Travis C. Mickle, Ph.D (Filed With SEC on January 9, 2023)
- Amendment to Employment Agreement, dated as of January 6, 2023, between KemPharm, Inc. and Richard W. Pascoe (Filed With SEC on January 9, 2023)
- Seventh Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 12, 2022)
- Executive Employment Agreement by and between the Registrant and Richard W. Pascoe, dated as of November 5, 2021 (Filed With SEC on November 10, 2021)
- Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on August 13, 2021)
- Sixth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 12, 2021)
- Fifth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on June 24, 2020)
- Fourth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on November 14, 2019)
- Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under 2014 Equity Incentive Plan (Filed With SEC on May 14, 2019)
- Amended Non-Employee Director Compensation Policy (Filed With SEC on March 1, 2019)
- Separation Agreement and General Release by and between the Registrant and Daniel L. Cohen, dated as of September 5, 2018 (Filed With SEC on November 9, 2018)
- KemPharm, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 30, 2018)
- KemPharm, Inc. Amended and Restated Employment Agreement Sven Guenther Effective as of April 13, 2016 KemPharm, Inc. Amended and Restated Employment Agreement (Filed With SEC on May 13, 2016)
- KemPharm, Inc. Employment Agreement Daniel L. Cohen Effective as of April 13, 2016 KemPharm, Inc. Employment Agreement (Filed With SEC on May 13, 2016)
- KemPharm, Inc. Non-Employee Director Compensation Policy (Filed With SEC on March 16, 2016)
- Amendment to Employment Agreement (Filed With SEC on November 13, 2015)
- Amendment to Employment Agreement (Filed With SEC on November 13, 2015)
- Amendment to Amended and Restated Employment Agreement (Filed With SEC on November 13, 2015)
- Amendment to Amended and Restated Employment Agreement (Filed With SEC on November 13, 2015)
- Amendment to Employment Agreement (Filed With SEC on November 13, 2015)
- KemPharm, Inc. Amended and Restated Employment Agreement (Filed With SEC on August 14, 2015)
- KemPharm, Inc. Amended and Restated Employment Agreement (Filed With SEC on August 14, 2015)
- KemPharm, Inc. Employment Agreement (Filed With SEC on August 14, 2015)
- KemPharm, Inc. Employment Agreement Tracy Woody Dated March 30, 2015 KemPharm, Inc. Employment Agreement (Filed With SEC on May 29, 2015)
- KEMPHARM, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:NOVEMBER 7, 2014 APPROVED BY THE STOCKHOLDERS:APRIL 1, 2015 IPO DATE/EFFECTIVE DATE: , 2015 (Filed With SEC on April 3, 2015)
- KEMPHARM, INC. INCENTIVE STOCK PLAN (Filed With SEC on April 3, 2015)
